Definition
The treatment of a biologically embodied outcome at the individual level while the material conditions contributing to its production remain structurally intact.
HAKKI TAN · REALITY PARADIGM · HT–09
Pharmacological Individualisation
The treatment of a biologically embodied outcome at the individual level while the material conditions contributing to its production remain structurally intact.
“Clinical efficacy and structural sufficiency are different questions.”
CANONICAL DEFINITIONHT–09
What is Pharmacological Individualisation?
Within Hakkı Tan's Reality Paradigm research programme, Pharmacological Individualisation names the treatment of a biologically embodied outcome at the individual level while the material conditions contributing to its production remain structurally intact.
Analytical question
What does an effective treatment change in the body, and which prices, formulations, access inequalities, and social stressors remain unchanged outside it?
Conceptual boundary
The concept is not an argument against medicine or GLP-1 therapies. It explicitly separates demonstrated clinical benefit from the wider claim that treatment has transformed the conditions producing the need for treatment.
Place in the research programme
It identifies the intervention stage of Metabolic Ambush, where a structural history can be addressed primarily through the individual body.
RELATED TERMS AND FORMS
Pharmacological IndividualisationFarmakolojik BireyselleştirmePharmacological individualizationİlaçla bireyselleştirme
SUGGESTED CITATION
Tan, Hakkı. “Pharmacological Individualisation.” Hakkitan.org — Hakkı Tan Research Archive, 2026. https://hakkitan.org/concepts/pharmacological-individualisationhttps://hakkitan.org/concepts/pharmacological-individualisation